Trial intelligence / Profile preview

Dexlansoprazole MR Maintenance in Healed Erosive Esophagitis

NCT00255164Phase 3Completed

Sponsor
Takeda
Start
Jan 2006
Primary completion
Nov 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of dexlansoprazole in erosive esophagitis (EE), sponsored by Takeda. Started Jan 2006; status: completed.

02

Drugs

dexlansoprazole
03

Conditions

erosive esophagitis (EE)

Beyond the preview

Go deeper on NCT00255164.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00255164.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call